Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01214
|
|||||
| Drug Name |
Kanamycin
|
|||||
| Synonyms |
(1S,2R,3R,4S,6R)-4,6-diamino-3-(6-amino-6-deoxy-alpha-D-glucopyranosyloxy)-2-hydroxycyclohexyl 3-amino-3-deoxy-alpha-D-glucopyranoside; (1S,2R,3R,4S,6R)-4,6-diamino-3-[(6-amino-6-deoxy-alpha-D-glucopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-3-deoxy-alpha-D-glucopyranoside; (1S,2R,3R,4S,6R)-4,6-diazaniumyl-3-(6-azaniumyl-6-deoxy-alpha-D-glucopyranosyloxy)-2-hydroxycyclohexyl 3-azaniumyl-3-deoxy-alpha-D-glucopyranoside; (2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol; 4,6-Diamino-2-hydroxy-1,3-cyclohexane 3,6'diamino-3,6'-dideoxydi-alpha-D-glucoside; 4,6-diamino-2-hydroxy-1,3-cyclohexylene 3,6'-diamino-3,6'-dideoxydi-D-glucopyranoside; Aspidium; KAN; KANAMYCIN A; KM (the Antibiotic); Kanamicina; Kanamicina [Italian]; Kanamycin A tetracation; Kanamycin Base; Kanamycin [INN:BAN]; Kanamycin monosulfate; Kanamycin monosulfate (JP15); Kanamycin sulfate; Kanamycin sulfate (TN); Kanamycin sulfate (USP); Kanamycine; Kanamycine [INN-French]; Kanamycinsulfate (JP15); Kanamycinum; Kanamycinum [INN-Latin]; Kantrex; Kantrex (1:1 sulfate); Kantrex (TN); Kenamycin A; Klebcil; Klebcil (1:1 sulfate); Liposomal Kanamycin; O-3-Amino-3-deoxy-.alpha.-D-glucopyranosyl-(1->6)-O-[6-amino-6-deoxy-.alpha.-D-glucopyranosyl-(1->4)]-2-deoxy-D-streptamine; O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->4))-2-deoxy-D-streptamine
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Antibiotics
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C18H40N4O11+4
|
|||||
| Canonical SMILES |
C1C(C(C(C(C1[NH3+])OC2C(C(C(C(O2)C[NH3+])O)O)O)O)OC3C(C(C(C(O3)CO)O)[NH3+])O)[NH3+]
|
|||||
| InChI |
InChI=1S/C18H36N4O11/c19-2-6-10(25)12(27)13(28)18(30-6)33-16-5(21)1-4(20)15(14(16)29)32-17-11(26)8(22)9(24)7(3-23)31-17/h4-18,23-29H,1-3,19-22H2/p+4/t4-,5+,6-,7-,8+,9-,10-,11-,12+,13-,14-,15+,16-,17-,18-/m1/s1
|
|||||
| InChIKey |
SBUJHOSQTJFQJX-NOAMYHISSA-R
|
|||||
| CAS Number |
CAS 8063-07-8
|
|||||
| Pharmaceutical Properties | Molecular Weight | 488.5 | Topological Polar Surface Area | 289 | ||
| Heavy Atom Count | 33 | Rotatable Bond Count | 6 | |||
| Hydrogen Bond Donor Count | 11 | Hydrogen Bond Acceptor Count | 11 | |||
| XLogP |
-6.9
|
|||||
| PubChem CID | ||||||
| PubChem SID | ||||||
| ChEBI ID |
ChEBI:6104
|
|||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.